Totaligent and GloMed Solutions sign LOI for joint venture

Totaligent, Inc. and GloMed Solutions LLC signed a binding letter of intent to form a joint venture integrating Totaligent's Aetherium Medical platform with GloMed's operations in Japan and APAC. The JV is expected to close within four weeks, with Totaligent holding strategic control via three board seats.

“This Binding Letter of Intent sets forth the binding agreement and understanding between Totaligent, Inc. and GloMed Solutions Limited Liability Company regarding the proposed formation of a joint venture”sec.gov

• 1 source
• sec.govtotaligent_ex101.htmFeb 22, 2026

Summarized from public sources; check the original articles before acting on it.